Literature DB >> 7250747

Effect of endogenous pancreatic glucagon on gastric acid secretion in patients with duodenal ulcer before and after parietal cell vagotomy.

F B Loud, J Chirstiansen, J J Holst, B Petersen, P Kirkegaard.   

Abstract

The effect of endogenous pancreatic glucagon on submaximal pentagastrin stimulated gastric acid secretion was studied by infusion of 1-arginine in patients with duodenal ulcer before and after parietal cell vagotomy without drainage (PCV). Preoperatively infusion of 1-arginine resulted in a marked inhibition of acid secretion, whereas no effect was found postoperatively. Plasma glucagon concentrations were identical pre- and postoperatively, fasting as well as during arginine infusion. Serum gastrin concentration rose after PCV but not unaffected by arginine infusion both pre- and postoperatively. The study demonstrates that intact vagal innervation of the fundic glands is a condition of inhibition of pentagastrin induced acid secretion by pancreatic glucagon released by infusion of 1-arginine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7250747      PMCID: PMC1419251          DOI: 10.1136/gut.22.5.359

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer.

Authors:  J I Isenberg; M I Grossman; V Maxwell; J H Walsh
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

2.  Interrelations between serum gastrin levels, gastric emptying and acid output before and after proximal gastric vagotomy and truncal vagotomy and antrectomy.

Authors:  I A Donovan; C Owens; B G Clendinnen; D W Griffin; L K Harding; J Alexander-Williams
Journal:  Br J Surg       Date:  1979-03       Impact factor: 6.939

3.  Determination of serum or plasma glucose on the "AutoAnalyzer II" by use of the hexokinase reaction.

Authors:  G M Widdowson; J R Penton
Journal:  Clin Chem       Date:  1972-03       Impact factor: 8.327

4.  Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay.

Authors:  F Stadil; J F Rehfeld
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  The effect of vagotomy on the lower part of the acid dose-response curve to pentagastrin in man.

Authors:  J B Elder; G Gillespie; E H Campbell; I E Gillespie; G P Crean; A W Kay
Journal:  Clin Sci       Date:  1972-08       Impact factor: 6.124

6.  Radioimmunoassay of gastrin in human serum.

Authors:  F Stadil; J F Rehfeld
Journal:  Scand J Gastroenterol Suppl       Date:  1971

7.  Evidence that glicentin contains the entire sequence of glucagon.

Authors:  J J Holst
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

8.  Effect of arginine on serum-levels of human growth-hormone.

Authors:  T J Merimee; D A Lillicrap; D Rabinowitz
Journal:  Lancet       Date:  1965-10-02       Impact factor: 79.321

9.  Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon.

Authors:  J Christiansen; J J Holst; E Kalaja
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

10.  Squamous-cell carcinoma of the anus.

Authors:  J Christiansen; M Vittrup
Journal:  Acta Chir Scand       Date:  1975
View more
  4 in total

1.  Effect of glucagon on vagally induced gastric acid secretion in humans.

Authors:  F B Loud; J J Holst; J Christiansen; J F Rehfeld
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

2.  Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia.

Authors:  F B Loud; J J Holst; J F Rehfeld; J Christiansen
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

Review 3.  Discovery of the GI Effects of GLP-1: An Historical Perspective.

Authors:  Jens Juul Holst
Journal:  Dig Dis Sci       Date:  2022-05-30       Impact factor: 3.487

4.  Effect of proximal gastric vagotomy on calculated gastric HCO3- and nonparietal volume secretion in man. Studies during basal conditions and gastrin-17 infusion.

Authors:  M Feldman; A J Blair; C T Richardson
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.